1. Home
  2. ATXS vs MITK Comparison

ATXS vs MITK Comparison

Compare ATXS & MITK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATXS
  • MITK
  • Stock Information
  • Founded
  • ATXS 2008
  • MITK 1983
  • Country
  • ATXS United States
  • MITK United States
  • Employees
  • ATXS N/A
  • MITK N/A
  • Industry
  • ATXS Biotechnology: Pharmaceutical Preparations
  • MITK Computer peripheral equipment
  • Sector
  • ATXS Health Care
  • MITK Technology
  • Exchange
  • ATXS Nasdaq
  • MITK Nasdaq
  • Market Cap
  • ATXS 401.2M
  • MITK 463.1M
  • IPO Year
  • ATXS 2015
  • MITK N/A
  • Fundamental
  • Price
  • ATXS $6.81
  • MITK $9.31
  • Analyst Decision
  • ATXS Strong Buy
  • MITK Strong Buy
  • Analyst Count
  • ATXS 6
  • MITK 4
  • Target Price
  • ATXS $25.67
  • MITK $12.88
  • AVG Volume (30 Days)
  • ATXS 244.9K
  • MITK 565.2K
  • Earning Date
  • ATXS 03-03-2025
  • MITK 02-10-2025
  • Dividend Yield
  • ATXS N/A
  • MITK N/A
  • EPS Growth
  • ATXS N/A
  • MITK N/A
  • EPS
  • ATXS N/A
  • MITK 0.10
  • Revenue
  • ATXS N/A
  • MITK $172,420,000.00
  • Revenue This Year
  • ATXS N/A
  • MITK $3.75
  • Revenue Next Year
  • ATXS N/A
  • MITK $10.80
  • P/E Ratio
  • ATXS N/A
  • MITK $96.64
  • Revenue Growth
  • ATXS N/A
  • MITK 5.28
  • 52 Week Low
  • ATXS $6.64
  • MITK $7.35
  • 52 Week High
  • ATXS $16.90
  • MITK $16.24
  • Technical
  • Relative Strength Index (RSI)
  • ATXS 31.94
  • MITK 36.05
  • Support Level
  • ATXS $6.77
  • MITK $9.06
  • Resistance Level
  • ATXS $7.30
  • MITK $10.47
  • Average True Range (ATR)
  • ATXS 0.30
  • MITK 0.36
  • MACD
  • ATXS 0.02
  • MITK -0.13
  • Stochastic Oscillator
  • ATXS 14.66
  • MITK 12.14

About ATXS Astria Therapeutics Inc.

Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.

About MITK Mitek Systems Inc.

Mitek Systems Inc is engaged in the development, sale, and service of proprietary software solutions related to mobile imaging. The firm is a software development company with expertise in artificial intelligence, and machine learning. It serves more than 7,900 financial services organizations, financial technology (fintech) brands, telecommunications companies, and marketplace brands across the globe. The company's Mobile Deposit solution is used by consumers for mobile check deposits. The company's Mobile Verify verifies a user's identity online enabling organizations to build safer digital communities, whereas CheckReader enables financial institutions to automatically extract data from a check image received across any deposit channel - branch, ATM, RDC, and mobile.

Share on Social Networks: